Drugs / MMV055
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT07011511 | Jun 2025 → Dec 2027 expected | Plasmodium falciparum malaria | Medicines for Malaria Venture | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | MMV055 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07011511 ↗ |
| Route | Intramuscular | “Intramuscular Injection(s) of Long-Acting Injectable Formulations of MMV055 Alone (Part A) and in Combination With MMV371 (Part B)” NCT07011511 ↗ |